2025
Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement
Oprea A, Ostapenko L, Sweitzer B, Selzer A, Irizarry-Alvarado J, Hurtado Andrade M, Mendez C, Kelley K, Stewart E, Fernandez Robles C, Chadha R, Camilleri M, Mathur R, Umpierrez G, Hepner D. Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement. British Journal Of Anaesthesia 2025, 135: 48-78. PMID: 40379536, DOI: 10.1016/j.bja.2025.04.001.Peer-Reviewed Original ResearchConceptsGlucagon-like peptide 1 receptor agonistsPeptide 1 receptor agonistsPerioperative management of patientsMultidisciplinary consensus statementManagement of patientsSociety for Perioperative AssessmentPerioperative managementPerioperative assessmentConsensus statementPreoperative fasting timeMedical managementAgonistsModified Delphi processPatientsSystematic review
2022
Preoperative Management of Cardiovascular Medications: A Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement
Sahai SK, Balonov K, Bentov N, Bierle DMM, Browning LM, Cummings KC, Dougan BM, Maxwell M, Merli GJ, Oprea AD, Sweitzer B, Mauck KF, Urman RD. Preoperative Management of Cardiovascular Medications: A Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement. Mayo Clinic Proceedings 2022, 97: 1734-1751. PMID: 36058586, DOI: 10.1016/j.mayocp.2022.03.039.Peer-Reviewed Original ResearchConceptsCardiovascular medicationsPerioperative assessmentAntiarrhythmic agentsReceptor antagonistAngiotensin receptor neprilysin inhibitorQuality Improvement (SPAQI) Consensus StatementAngiotensin II receptor blockersClass I antiarrhythmic agentsClass III antiarrhythmic agentII receptor blockersClasses of medicationsEndothelin receptor antagonistsPotassium-sparing diureticsCalcium channel blockersÎ’-adrenoceptor blockersAdrenergic receptor antagonistPhosphodiesterase-5 inhibitorsEvidence-based recommendationsSodium channel blockersPotassium channel openersSympatholytic medicationsReceptor blockersPerioperative managementHeart failureLoop diureticsPreoperative Management of Medications for Rheumatologic and HIV Diseases: Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement
Russell LA, Craig C, Flores EK, Wainaina JN, Keshock M, Kasten MJ, Hepner DL, Edwards AF, Urman RD, Mauck KF, Oprea AD. Preoperative Management of Medications for Rheumatologic and HIV Diseases: Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement. Mayo Clinic Proceedings 2022, 97: 1551-1571. PMID: 35933139, DOI: 10.1016/j.mayocp.2022.05.002.Peer-Reviewed Original ResearchConceptsPerioperative medication managementPerioperative assessmentConsensus statementPreoperative managementMedication managementQuality Improvement (SPAQI) Consensus StatementEvidence-based perioperative careAnti-inflammatory medicationsPerioperative medical managementInfectious disease specialistsLong-term medicationInternal medicine physiciansComplexity of patientsPreoperative optimizationHIV diseaseCommon medicationsPerioperative careMedical managementDisease specialistsClinical guidanceConsensus recommendationsSurgical proceduresMedicine physiciansMedicationsExpert consensusPreoperative Management of Medications for Psychiatric Diseases Society for Perioperative Assessment and Quality Improvement Consensus Statement
Oprea AD, Keshock MC, O'Glasser AY, Cummings KC, Edwards AF, Zimbrean PC, Urman RD, Mauck KF. Preoperative Management of Medications for Psychiatric Diseases Society for Perioperative Assessment and Quality Improvement Consensus Statement. Mayo Clinic Proceedings 2022, 97: 397-416. PMID: 35120702, DOI: 10.1016/j.mayocp.2021.11.011.Peer-Reviewed Original ResearchConceptsPsychiatric medication managementPreoperative managementPerioperative assessmentMedication managementConsensus statementQuality Improvement (SPAQI) Consensus StatementAttention deficit hyperactivity disorder medicationsDay of surgeryRisk of relapseHyperactivity disorder medicationsCategories of drugsMedication classesPerioperative complicationsDiseases SocietyMost medicationsIndividual medicationsMood stabilizersPsychiatric medicationsConsensus recommendationsMedicationsDrug categoriesCertain drugsPatient carePsychiatric conditionsProcedure cancellationsPreoperative Management of Medications for Neurologic Diseases Society for Perioperative Assessment and Quality Improvement Consensus Statement
Oprea AD, Keshock MC, O'Glasser AY, Cummings KC, Edwards AF, Hunderfund AL, Urman RD, Mauck KF. Preoperative Management of Medications for Neurologic Diseases Society for Perioperative Assessment and Quality Improvement Consensus Statement. Mayo Clinic Proceedings 2022, 97: 375-396. PMID: 35120701, DOI: 10.1016/j.mayocp.2021.11.010.Peer-Reviewed Original ResearchConceptsPreoperative managementPerioperative assessmentNeurologic disordersQuality Improvement (SPAQI) Consensus StatementEvidence-based recommendationsPerioperative medicationsDiseases SocietyPerioperative cliniciansSocietal guidelinesConsensus statementNeurologic diseaseConsensus recommendationsInvasive proceduresMedicationsDrug substitutionIndividualized approachAnesthesia practicePerioperative medicineInternal medicineDisordersPatientsLaboratory testingMedicineManagementClinicians
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply